Link Securities | Judge José Luis Calama of the National Court, who is investigating the Grifols case, has asked the National Securities Market Commission (CNMV) to send him a document supporting Gotham’s accusations, arguing that the Catalan pharmaceutical company omitted relevant data in its accounts and provided the market with inaccurate information, as reported yesterday by the digital newspaper ElConfidencial.com. The regulator’s report, which analyses the accusations of the bear…

Link Securities | The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson’s Disease Research to identify plasma-based biomarkers that could indicate a person’s likelihood of developing Parkinson’s disease (PD) “many years before” clinical diagnosis. The initiative, dubbed ‘Chronos PD’, could accelerate the discovery of new diagnostic tools, as well as the identification and development of novel therapies that modify…

Link Securities | Grifols (GRF) informed the National Securities Market Commission (CNMV), in relation to a bond issue reported on 11 December that: the Bonds have been issued and the proceeds have been received and, therefore, the issue has been completed. The net proceeds of the issue have been used (i) together with cash on hand, to redeem in full on 27 December 2024 GRF’s 1.625% Senior Secured Notes due…

Bankinter: The company is to issue soon €1.3 billion in Guaranteed Bonds maturing in May 2023 with a coupon of 7.125%. Together with part of the cash (September: €644 million), it will be used to redeem close on €340 million of Senior Secured Bonds maturing in February 2025 with a coupon of 1.625% and to pay off the working capital loan facility maturing in November 2025. It also extends by…

Link Securities | Grifols (GRF) is in negotiations with banks to refinance bonds maturing next year and a credit line, for a combined amount of €1.4 billion, as confirmed by the CEO of the pharmaceutical company, Nacho Abia, in an interview with Bloomberg reported by the digital portal Bolsamania.com. Abia explained that the company’s ‘plan A’ is to obtain a refinancing agreement for the €370 million in bonds maturing in…

Santander Credit Research | Grifols (B+ s, B+ s) yesterday informed the CNMV that it has received a non-binding offer from Brookfield that considers a price of €10.50 per class A share and a price of €7.62 per class B share, which would imply valuing Grifols’ equity at €6.5 billion. According to the relevant fact communicated to the CNMV, Brookfield last week sent letters to Grifols’ Transaction Committee, constituted by…